Company Filing History:
Years Active: 2020
Title: Jim Heimbach: Innovator in Biopharmaceutical Processing
Introduction
Jim Heimbach is a notable inventor based in Springvale, Maine, who has made significant contributions to the field of biopharmaceutical processing. With a focus on improving equipment used in this industry, Heimbach has developed innovative solutions that enhance the efficiency and effectiveness of biopharmaceutical production.
Latest Patents
Heimbach holds a patent for "Reactor Surface Finish Remediation," which addresses the challenges associated with biopharmaceutical processing equipment, such as reactor vessels and stainless steel surfaces. This patent outlines methods for determining and improving the surface roughness of equipment that comes into contact with proteinaceous processing materials. Specifically, it emphasizes the importance of maintaining a pre-commissioning surface roughness of greater than about 20 Ra Max (μin) to ensure optimal performance.
Career Highlights
Throughout his career, Heimbach has worked with prominent companies in the biopharmaceutical sector, including Lonza Inc. and Glaxo Group Limited. His experience in these organizations has allowed him to gain valuable insights into the industry's needs and challenges, further informing his innovative approaches.
Collaborations
Heimbach has collaborated with talented professionals in the field, including Michael Mietzner and Andrew Mitchell Harris. These partnerships have contributed to the development of his patent and have fostered a collaborative environment for innovation.
Conclusion
Jim Heimbach's contributions to biopharmaceutical processing through his innovative patent demonstrate his commitment to advancing the industry. His work not only enhances equipment performance but also reflects the importance of continuous improvement in biopharmaceutical manufacturing.